miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Abeona Therapeutics Receives FDA Rare Pediatric Disease Designation for ABO-202 Gene Therapy Program in CLN1 Disease Pharmaceutical Investing
Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Fragile X Syndrome Pharmaceutical Investing
Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update Pharmaceutical Investing
ContraFect Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Biotech Investing
Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results Pharmaceutical Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
